Genetic polymorphism of drug metabolizing enzymes and estrogen receptor in pharmacogenetics of tamoxifen: implication for optimization of breast cancer treatment / Teh Lay Kek and Mohd Zaki Salleh
Introduction: Tamoxifen has been used as a hormonal therapy in breast cancer patients who are positive for estrogen receptor. The drug is metabolized by Cytochrome P450 2D6 (CYP2D6) into several metabolite. Variation in CYP2D6 activity has important therapeutic consequences and can play a significan...
Main Authors: | , |
---|---|
Format: | Research Reports |
Language: | English |
Published: |
Research Management Institute (RMI)
2010
|
Subjects: | |
Online Access: | http://ir.uitm.edu.my/id/eprint/24806/ http://ir.uitm.edu.my/id/eprint/24806/1/LP_TEH%20LAY%20KEK%20RMI%2010_5.pdf |